Methods and compositions for the detection of soluble beta-amyloid peptide

Details for Australian Patent Application No. 2008200489 (hide)

International Classifications

Event Publications

21 February 2008 Complete Application Filed

28 February 2008 Application Open to Public Inspection

Published as AU-B-2008200489

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

24 June 2010 Section 223 Application Received

Elan Pharmaceuticals, Inc.; The Brigham and Women's Hospital, Inc.; Eli Lilly and Company An application to extend the time from 01 Sep 2009 to 01 Apr 2010 in which to pay a continuation fee has been filed . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2009

19 August 2010 Section 223 Application Allowed

Elan Pharmaceuticals, Inc.; The Brigham and Women's Hospital, Inc.; Eli Lilly and Company The time in which to pay a continuation fee has been extended to 01 Apr 2010. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

28 October 2010 Application Accepted

Published as AU-B-2008200489

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.